Latest News about NVO
Recent news which mentions NVO
From Motley Fool
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
From Motley Fool
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
April 12, 2024
From Benzinga
Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy
April 12, 2024
From Benzinga
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
April 12, 2024
From Benzinga
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
April 12, 2024
From InvestorPlace
From InvestorPlace
What's Going On With Ginkgo Bioworks Stock?
April 11, 2024
From Benzinga
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
April 11, 2024
From InvestorPlace
3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
April 10, 2024
From InvestorPlace
2 Healthcare Stocks to Buy Hand Over Fist in April
April 10, 2024
From Motley Fool
Tickers
NVO
From Motley Fool
From Motley Fool
From Motley Fool
From InvestorPlace
Assessing Novo Nordisk: Insights From 10 Financial Analysts
April 05, 2024
Tickers
NVO
From Benzinga
Tickers
NVO
From Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
From Motley Fool
Why Eli Lilly Stock Topped the Market Today
April 03, 2024
From Motley Fool
Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
April 03, 2024
From Benzinga
Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China
April 03, 2024
From Benzinga
From InvestorPlace
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
April 03, 2024
From Benzinga
5 Healthcare Stocks to Buy for 2024
April 02, 2024
From InvestorPlace
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
From Benzinga
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand
April 02, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.